Regeneron Pharmaceuticals(REGN) · US
Sector: XLV | Last updated: 28 Aug 2026
Regeneron Pharmaceuticals (REGN) is showing Bullish momentum today, with an Altra Score of 71.2 on AltraOne's multi-timeframe (MTF) momentum analysis. The stock is part of the XLV sector, where it ranks 32 by relative strength in a currently neutral RS regime (Relative Strength: 464.00). There are no active EMA crossover signals at the moment. REGN closed at 794.19 on 28 Aug 2026 (-1.88% for the day), based on end-of-day (EOD) price data rather than a live quote.
Price
Stock Relative Strength
Latest EMA CrossOvers
No active signals
REGN's Daily RSI(14) is 55.9 (down 5.7 from prior), Weekly RSI is 61.1 (down 7.3 from prior), and Monthly RSI is 62.2 (up 2.3 from prior). Price is currently trading above its Daily EMA 20, Daily EMA 50, Daily EMA 200, Weekly EMA 8, Weekly EMA 30, but below its Daily EMA 8.
Multi-Timeframe RSI (14)
| Timeframe | RSI | Prev | Change |
|---|---|---|---|
| Daily | 55.9 | 61.6 | ▼ 5.7 |
| Weekly | 61.1 | 68.3 | ▼ 7.3 |
| Monthly | 62.2 | 59.9 | ▲ 2.3 |
Stock Price and EMA Placement
History
TradingView ↗The current active signal for REGN is Bullish, triggered on 03 Aug 2026 at a price of 759.24. Since then, the stock has gained 4.60%.
These are long-term momentum shifts, not buy/sell recommendations.